Search clinical trials for: Fentanyl Transdermal System 25 mcg/h

Total 187 results

Mylan Pharmaceuticals Inc

Terminated

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay

Healthy

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Fentanyl Single and Multidose PK

Breakthrough Pain

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

Healthy

Canada
Nigde Omer Halisdemir University

Completed

Use of Intrathecal Analgesia in Appendectomy

Analgesia | Anesthesia
Khon Kaen University

Completed

Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial

Postoperative Pain Relief

Thailand
Fujian Cancer Hospital

Unknown

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
Janssen Pharmaceutical K.K.

Completed

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Pain | Cancer

Japan
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers

Healthy

Belgium
Alza Corporation, DE, USA

Withdrawn

An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

Pain, Postoperative | Pediatrics
Cairo University
Norhan Abdel Aleem Ali; Hagar hassanein refaee; Ahmed Abdullah Fathi Mohamed...

Completed

A Comparative Study on Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl for Optimal Dose to be Used in Elderly Patients Undergoing Day Case Lower Abdominal and Urologic Surgeries.

Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl

Egypt
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Pain | Cancer

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Pain

United States
GlaxoSmithKline

Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

Asthma

United States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
Cephalon

Completed

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Pain | Cancer

United States
ZARS Pharma Inc.

Completed

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Pain

United States
Johns Hopkins University
PriCara, Unit of Ortho-McNeil, Inc.

Completed

Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

Peripheral Neuropathy | Complex Regional Pain Syndromes (CRPS)
GlaxoSmithKline

Completed

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

Asthma

Australia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
Johnson & Johnson Taiwan Ltd

Completed

Fentanyl for Treatment Pain Caused by Radiotherapy

Pain
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

Arthritis | Osteoarthritis | Rheumatoid Arthritis
Chongqing University Cancer Hospital

Completed

Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients

Nutrition Disorders | Cancer Pain

China
Cristália Produtos Químicos Farmacêuticos Ltda.

Withdrawn

Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)

Pain | Palliative Care

Brazil
Medical University of Graz

Completed

Traumatologic Acute Pain Management With Fentanyl Transdermal Therapeutic System (TTS)

Hip Fractures (ICD-10 72.01-72.2)

Austria
Janssen-Cilag Ltd.

Completed

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Cancer, Pain
Baskent University

Completed

Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain

Postoperative Pain
Alza Corporation, DE, USA

Completed

Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

Pain | Cancer
GlaxoSmithKline

Withdrawn

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Canada, Germany
Assiut University

Completed

Postoperative Epidural Analgesia in Spine Fusion Surgery

Pain

Egypt
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Chronic Pain
GlaxoSmithKline

Completed

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

Asthma

New Zealand
Alza Corporation, DE, USA

Completed

Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

Pain | Cancer
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy

Chronic Pain
Ohio State University

Recruiting

Epidural Fentanyl for 2nd Stage Labor Analgesia

Labor Pain

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Pancreatic Cancer

United States
Akela Pharma, Inc.

Unknown

Safety of Fentanyl TAIFUN Treatment (FINDS)

Breakthrough Cancer Pain

Poland
Janssen Pharmaceutica N.V., Belgium

Completed

A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy

Chronic Pain
Khon Kaen University

Completed

Study of Transdermal Fentanyl Patch to Treat Postoperative Pain in Total Knee Arthroplasty (TFP)

Postoperative Pain

Thailand
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Totally Transdermal Sedation in the Weaning From Remifentanil Infusion (TOES)

Respiratory Insufficiency | Ventilator Weaning | Analgesics, Opioid

Italy
AstraZeneca

Completed

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma (PASSION)

Asthma

Turkey
South Egypt Cancer Institute

Unknown

Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy

Breast Cancer Female

Egypt
Louisiana State University Health Sciences Center...

Terminated

Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures

Necrosis | Surgical Wound Dehiscence | Fractures, Comminuted

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants

Healthy

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Pain

United States
Sandoz

Completed

Relative Bioavailability of a Fentanyl Patch

Pain
Northwestern University

Completed

The Effect of Neuraxial Analgesia on Maternal Breastfeeding

Pain | Breastfeeding

United States
GlaxoSmithKline

Completed

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Asthma

United States, Canada
Alza Corporation, DE, USA

Terminated

A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)

Pain

Germany, Austria, Finland, Netherlands
University Hospital Dubrava

Recruiting

Evaluation of Intraoperative Dexmedetomidine Use in Patients Undergoing Surgical Aortic Valve Replacement

Aortic Valve Stenosis | Systemic Inflammatory Response

Croatia

3

Subscribe